| HLS Stock | | | CAD 3.56 0.05 1.39% |
The current 90-days correlation between HLS Therapeutics and Medicenna Therapeutics Corp is 0.26 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as HLS Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if HLS Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
HLS Therapeutics Correlation With Market
Very weak diversification
The correlation between HLS Therapeutics and DJI is 0.43 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding HLS Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
The ability to find closely correlated positions to HLS Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HLS Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HLS Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HLS Therapeutics to buy it.
Moving against HLS Stock
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations | APS | | MDNA | | GUD | | MDNA | | APS | | GUD | | MDNA | | PRN |
| | High negative correlations |
Risk-Adjusted IndicatorsThere is a big difference between HLS Stock performing well and HLS Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze HLS Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Be your own money manager
Our tools can tell you how much better you can do entering a position in HLS Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
| | Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
HLS Therapeutics Corporate Management
Elected by the shareholders, the HLS Therapeutics' board of directors comprises two types of representatives: HLS Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HLS. The board's role is to monitor HLS Therapeutics' management team and ensure that shareholders' interests are well served. HLS Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HLS Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.